Ifp Advisors, Inc Assembly Biosciences, Inc. Transaction History

Ifp Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change
Q3 2021 Oct 06, 2021	SELL	$3.14 - $3.9 $0 - $0	0 Closed
Q2 2021 Jul 13, 2021	BUY	$3.8 - $4.56 $0 - $0	0 New
Q1 2021 Apr 30, 2021	BUY	$4.33 - $6.63 $0 - $0	0 New
Q4 2020 Jan 25, 2021	BUY	$4.87 - $17.29 $0 - $0	0 New
Q3 2020 Oct 29, 2020	BUY	$15.08 - $27.04 $0 - $0	0 New

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.